↓ Skip to main content

Dove Medical Press

Short- versus long-term dual antiplatelet therapy after second-generation drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials

Overview of attention for article published in Drug Design, Development and Therapy, June 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
46 Mendeley
Title
Short- versus long-term dual antiplatelet therapy after second-generation drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials
Published in
Drug Design, Development and Therapy, June 2018
DOI 10.2147/dddt.s165435
Pubmed ID
Authors

Hongqing Li, Wenqin Guo, Weiran Dai, Lang Li

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 15%
Student > Master 5 11%
Other 4 9%
Student > Postgraduate 4 9%
Student > Doctoral Student 3 7%
Other 9 20%
Unknown 14 30%
Readers by discipline Count As %
Medicine and Dentistry 16 35%
Pharmacology, Toxicology and Pharmaceutical Science 4 9%
Computer Science 2 4%
Nursing and Health Professions 2 4%
Arts and Humanities 1 2%
Other 5 11%
Unknown 16 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 September 2018.
All research outputs
#14,264,076
of 25,385,509 outputs
Outputs from Drug Design, Development and Therapy
#756
of 2,268 outputs
Outputs of similar age
#164,244
of 342,877 outputs
Outputs of similar age from Drug Design, Development and Therapy
#20
of 63 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,877 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.